PMC:7408073 / 77499-77724 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2752","span":{"begin":54,"end":62},"obj":"Species"},{"id":"2768","span":{"begin":174,"end":179},"obj":"Chemical"},{"id":"2769","span":{"begin":187,"end":191},"obj":"Chemical"},{"id":"2787","span":{"begin":7,"end":28},"obj":"Disease"},{"id":"2788","span":{"begin":32,"end":40},"obj":"Disease"}],"attributes":[{"id":"A2752","pred":"tao:has_database_id","subj":"2752","obj":"Tax:9606"},{"id":"A2787","pred":"tao:has_database_id","subj":"2787","obj":"MESH:D051436"},{"id":"A2788","pred":"tao:has_database_id","subj":"2788","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T394","span":{"begin":7,"end":28},"obj":"Disease"},{"id":"T395","span":{"begin":15,"end":28},"obj":"Disease"},{"id":"T397","span":{"begin":32,"end":40},"obj":"Disease"}],"attributes":[{"id":"A394","pred":"mondo_id","subj":"T394","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A395","pred":"mondo_id","subj":"T395","obj":"http://purl.obolibrary.org/obo/MONDO_0002118"},{"id":"A396","pred":"mondo_id","subj":"T395","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A397","pred":"mondo_id","subj":"T397","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T934","span":{"begin":127,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T935","span":{"begin":165,"end":166},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20258","span":{"begin":187,"end":190},"obj":"Chemical"}],"attributes":[{"id":"A18353","pred":"chebi_id","subj":"T20258","obj":"http://purl.obolibrary.org/obo/CHEBI_37256"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T143","span":{"begin":198,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0007588"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}

{"project":"2_test","denotations":[{"id":"32708755-32077115-20678932","span":{"begin":71,"end":72},"obj":"32077115"},{"id":"32708755-32161940-20678933","span":{"begin":73,"end":74},"obj":"32161940"},{"id":"32708755-32171076-20678934","span":{"begin":75,"end":76},"obj":"32171076"},{"id":"32708755-32109013-20678935","span":{"begin":79,"end":80},"obj":"32109013"},{"id":"32708755-32294485-20678936","span":{"begin":81,"end":82},"obj":"32294485"},{"id":"32708755-32091533-20678937","span":{"begin":83,"end":84},"obj":"32091533"},{"id":"32708755-31986264-20678938","span":{"begin":85,"end":86},"obj":"31986264"},{"id":"32708755-32297671-20678939","span":{"begin":87,"end":88},"obj":"32297671"},{"id":"32708755-22386035-20678940","span":{"begin":132,"end":134},"obj":"22386035"}],"text":"nce of chronic renal disease in COVID-19 hospitalized patients (0–3%) [1,2,3,4,5,6,7,8,9] (prevalence of the disease in China ~11% [12]) which might be protected by a higher sACE2 and/or Zn2+ renal excretion. Indeed, in chron"}